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Abstract:  A large variety of unique  N-atom containing compounds (alkaloids) without 
terrestrial counterparts, have been isolated from marine invertebrates, mainly sponges and 
ascidians. Many of these compounds display interesting biological activities. In this report 
we present studies on nitrogenous compounds, isolated by our group during the last few 
years, from Indo-Pacific sponges, one ascidian and one gorgonian. The major part of the 
review deals with metabolites from the Madagascar sponge Fascaplysinopsis sp., namely, 
four groups of secondary metabolites, the salarins, tulearins, taumycins and tausalarins. 
Keywords:  heterocycles;  Fascaplysinopsis  sp.;  marine  invertebrates;  nitrogenous 
macrolide; leukemia cells 
 
1. Introduction  
This report is an update of an earlier report of recent N-atom containing compounds [1] isolated by 
us between 2007 and 2010. The report includes organisms collected near Tanzania and along the west 
coast of Madagascar; the major part of the report deals with four groups of compounds isolated from 
the Madagascar Fascaplysinopsis sp. sponge. Our investigation of marine invertebrates started in 1972 
on Red Sea soft corals, sponges and tunicates. The first N-atom containing compound isolated by us 
was a N-acyl-2-methylene--alanine derivative, isolated from the sponge Fasciospongia cavernosa [2]. 
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To start with, there is the issue of the definition of alkaloids; namely, are all N-atom containing 
compounds alkaloids? The historical definition of ―alkaloids‖ was: basic (alkaline like) plant derived, 
amino acid, metabolites. During the years, the term was also used for animal metabolites, well known 
for example, are frog alkaloids; furthermore, often the N-atom is a non-basic amide moiety. On the 
other hand, other basic compounds were defined as biological compounds or polyamines. The most 
common current definition was given in S.W. Pelletier‘s Alkaloids book [3]
 namely,
 ―a cyclic organic 
compound containing nitrogen in a negative oxidation state which is of limited distribution among 
living organism‖. There are quite a few unclear issues, such as, has the nitrogen atom to be part of the 
ring (is it required to be a heterocyclic one)? do cyclic peptides and depsipeptides belong? etc. On the 
other hand, the term N-atom containing compounds seems to be too broad, not focused enough [4]. 
An  assembly  of  more  special  N-atom  containing  compounds,  isolated  by  us  over  the  years,  is 
depicted in Figure 1. 
Figure 1. An assembly of unique marine alkaloids isolated by us. 
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Cyclic peptides are an example of compounds for which the term alkaloid is not usually applied. 
One example would be the Didemnum molle cyclic peptides. 
Ascidians of the genera Lissoclinum and Didemnum are prolific producers of cyclic peptides [5],
 
many of which incorporate modified amino acid residues containing thiazole, oxazole, thiazoline or 
oxazoline  rings.  Similar  structures  have  been  reported  from  cyanobacteria  [6],  which  led  to  the 
suggestion that the ascidian peptides were produced by symbiotic cyanobacteria. Among the many 
interesting cyclic peptides isolated from D. molle are comoramides A and B and didmolamide A and B 
(Figure 2) [7]. From yet another D molle, collected in Madagascar, we isolated didmolamide A and B 
and a new congener designated didmolamide C (Figure 2) differing from A and B in the oxidation state 
of the heterocyclic rings [8]. 
Figure 2. Cyclic hexapeptides isolated from Didemnum molle. 
S
N
O
HN HN O
N
O
N
H
O
S N
didmolamide C,  a new cyclic 
          hexapeptide
Phe
mOzl
Ala
Tzn
Ala
Tzn
N
S HN
O
HN
O
N
O HN
O NH
O
Me
H
H
H
H
H
Me
Me
Me
Ph
O
Me
Me
Me
Ile
Ala
Phe
Thr-ether
Tzn
mOzn
(Thr )
comoramide  A &  ( B )
S
N
N
O
N S
NH
O
N
O
H
H
H
CH3
H
H3C
CH3
H Ph
NH
O
H
Phe
Ala
Ala
Tzl
Tzl
mOzn
didmolamide A ( mOzn)
didmolamide B ( Thr )
( Thr )
 
A major justification for exploring marine natural compounds are their unique structures with no 
terrestrial  counterparts,  many  of  which  possess  interesting  biological  activities,  thus  becoming 
excellent  drug  leads.  Three  exam ples  from  our  earlier  isolated  compounds ,  namely,  eilatin, 
violatinctamine and callynormine A [9–12] follow. 
Among  the  more  special  heterocyclic  compounds  that  we  have  isolated,  is  the  symmetric 
tetraaza-heptacyclic compound, eilatin (Figure 1) [9]. Most intriguing was the biogenesis of eilatin that 
can be looked at as a bis-pyridoacridine. A suggested biosynthesis is depicted in Scheme 1. Indeed, 
eilatin  could  be  prepared  in  two  steps  from  two  marine  available  metabolites,  kynuramine  and 
chatechol [9,10]. 
The  biogenesis  of  violatinctamine,  another  interesting  alkaloid,  is  shown  in  Scheme  2. 
Violatinctamine, a new alkaloid, together with four other known metabolites were isolated from the 
tunicate Cystodytes cf. violatinctus collected in Kenya [11]. Violatinctamine has a unique heterocyclic 
skeleton which combines a benzothiazole unit and a dihydroisoquinoline unit (Scheme 2) [13]. The 
structure of violatinctamine was elucidated by interpretation of MS as well as 1D and 2D NMR spectra 
(Scheme 2) [11].  Mar. Drugs 2010, 8                       
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Scheme 1. Biomimetic two steps synthesis of eilatin. 
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Scheme 2. Tautomers of violatinctamine. 
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Benzothiazoles rarely occur as marine natural products. The first benzothiazoles from the marine 
biosphere were isolated from fermentation culture extracts of Micrococcus sp., a marine bacterium 
obtained  from  the  tissues  of  the  sponge  Tedania  ignis  [14].  The  latter  compounds  included 
2-mercaptobenzothiazole, 2-methylbenzothiazole, 2-hydroxybenzothiazole and 6-hydroxy-3-methyl-2-Mar. Drugs 2010, 8                       
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benzothiazolone. Another benzothiazole derivative designated S1319 was isolated from Dysidea sp. 
and exhibited bronchodialating activity [15]. 
The third example is that of callynormine A (Figure 3), the first compound of a new class of 
heterodetic  peptides  embodying  the  -amino--aminoacrylamide  functionality  (instead  of  the  ester 
group of depsipeptides) which we named cyclic endiamino peptides [12]. 
It is suggested that the endiamino group is derived from the condensation of the formyl group of 
FGly and the amino group of another amino acid (Ile in the case of callynormine A) (Scheme 3) [12]. 
Formylglycine (FGly) was reported for both eukaryotic and prokaryotic sulfatases located within the 
catalytic site of the enzyme [16,17]. It was shown that the formylglycine is generated by oxidation of 
cysteine  or  serine  and,  furthermore,  that  the  FGly  hydrate  is  covalently  sulfated,  or  covalently 
phosphorylated  during  catalysis.  To  the  best  of  our  knowledge,  there  are  no  reports  of  natural 
compounds embodying the endiamino group. Indeed, synthetic linear compounds with this group are 
known. The endiamino group is of special interest for the synthesis of biomimetic cyclic peptides, as it 
is  expected  to  introduce  additional  rigidity  into  their  structure.  We  demonstrated  the  synthesis  of 
several  cyclic  endiamino  peptides,  including  2-(1H)-pyrazinone,  which,  formally,  is  the  smallest 
member  of  this  new  group  [18].  We  also  demonstrated  the  preparation  of  endiamino  containing 
building  blocks  for  biomimetic  peptides  [18].  FGly  is  very  unstable.  However,  its  enol-tosylate 
derivative, prepared from serine, is stable and acts with amino groups as an aldehyde [19] to produce 
the  -amido--aminoacrylamide  functionality.  As  mentioned above, novel  marine natural  products 
serve as drug leads and more specifically, in the endiamino case, are a lead for cyclic endiamino 
peptides (Scheme 3 and 4). Furthermore, it could be shown that instead of the nucleophilic amino 
group attack on the tosyl enolate, the superior thiol can be used, thus, generating another new group of 
compounds, the thioenamino cyclic peptides [20] (Schemes 3 and 4). 
Figure 3. Callynormine A, a new type of cyclic peptide. 
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Scheme 3. Suggested biogenesis of the endiamino bond and the synthesis of an endiamino 
cyclichexapeptide. 
 
Scheme 4. The synthesis of cyclic endiamino and thioenamino peptides. 
 
2. Results and Discussion  
New N-atom containing compounds isolated by us during the last three years.  
2.1. Salaramides A and B  
From  the  Madagascar  sponge  Hippospongia  sp.  phylum  Porifera,  class  Demospongiae,  order 
Dictyoceratida, family Spongiida, we have isolated two new ʱ-oxoamides, designated salaramide A 
(main compound) and its higher homologue salaramide B (minor compound) as an inseparable mixture 
(Figure 4) [21]. 
ʱ-Oxoamides have not been reported, to the best of our knowledge, in marine sponges and never 
found  in  the  genus  Hippospongia.  The  structures  of  the  compounds  were  established  from  the 
HRESIMS and 1D and 2D NMR experiments [21]. Interestingly, acetylation of salaramide A, under Mar. Drugs 2010, 8                       
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the usual mild conditions, resulted in a triacetate due to acetylation, in addition to the two hydroxyls, of 
the enol-hydroxyl of the ʱ-oxoamide. The transformation of an ʱ-ketoamide to enolacetate is rare, but 
was reported earlier for an ʱ-oxolactame [21]. From a biogenetic point of view, the salaramides are 
unique  aminodihydroxyisobutyric  acid  derivatives,  i.e.,  the  amino  analogues  of  the  naturally  rare 
trihydroxyisobutyric acid. 
Figure 4. The structure of salaramide A and B (the 15-homologe). 
 
2.2. Plakinamine L  
The  marine  sponge  Corticium  sp.  represents  a  prolific  source  of  steroid  alkaloids  [22,23],  the 
majority of which are structurally related to plakinamine A [24], as they possess an amino group at C-3 
and a cyclic amine functionality on the side chain of a C29 steroidal framework. From the Madagascar 
Corticium  sp.  sponge  we  have  isolated  a  congener  of  plakinamine  A  designated  plakinamine  L  
(Figure 5) [25]. Plakinamine L was assigned the molecular formula C33H58N2 by combined HREIMS 
and 
13C NMR analyses, and its structure elucidated by 1D and 2D NMR spectra as well as comparisons 
with  known  plakinamines  [25].  Plakinamine  L,  is  the  first  member  of  the  group  with  an  acyclic  
side chain. 
Figure 5. The structure of plakinamine A. 
 
2.3. Saldedines A and B  
Two new dibromo proaporphine alkaloids, designated as saldedines A and B, were isolated from an 
unidentified Didemnidae tunicate, collected in Salary Bay, north of Tulear, Madagascar [26]. Plant 
proaporphine  alkaloids,  a  major  isoquinoline  group,  have  been  recognized  as  the  biosynthetic 
precursors of aporphine alkaloids bearing a wide range of oxygenated substitution patterns with mainly 
a spiro-cyclohexadienone ring system (Figure 6). These alkaloids have, so far, only been isolated from 
a species of the Papaveraceae plant [27]. 
Several of these alkaloids exhibit interesting biological activities [28]. To the best of our knowledge 
the present work is the first report of proaporphine alkaloids from a marine source, and for the first Mar. Drugs 2010, 8                       
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time of bromo proaporphines. As in many other cases, the real source of these compounds, the tunicate 
or  guest  microorganism,  is  unknown.  The  structure  elucidation  of  the  two  new  compounds  was 
achieved by HRESIMS and 1D and 2D NMR spectra [26]. Finally, a qualified single crystal was 
obtained  from  CH2Cl2,  enabling  X-ray  crystallographic  analysis  (Figure  6)  and  confirming 
unequivocally the structure of saldedine A. Interestingly, saldedine A crystallized as a racemic mixture 
in space group Pbca, wherein the two enantiomeric species are related by an inversion center. 
The biosynthesis of proaporphine alkaloids is derived in nature (plants) from oxidative phenolic 
coupling  of  the  benzylisoquinoline  alkaloide.  Whereas  proaprophines  are  not  known  from  marine 
sources  a  possible  benzylisoquinoline  precursor  was  previously  obtained  from  the  starfish 
Dermasterias imbricata [29]. 
Saldedines A and B were both tested for toxicity to brine shrimp (Artemia salina) and were found 
moderately active. Saldedine A shows a greater potency with a LD50 value of 4.4 μM, while saldedine 
B has a LD50 value of 10.9 μM. 
Figure 6. The structure of saldedines A and B (10-OH). 
 
2.4. Njaoamines G and H  
A  variety  of  sponge  extracts  were  screened  for  brine  shrimp  toxicity.  As  a  consequence,  we 
encountered  potent  activity  from  a  Neopetrosia  sp.  collected  off  Pemba  Island,  Tanzania. 
Bioassay-guided isolation of the active compounds resulted in the isolation of two new polycyclic 
alkaloids designated njaoamine G and H [30], belonging to the ‗njaoamine‘ family, represented by 
njaoamines  A–F,  isolated  recently  from  a  haplosclerid  sponge  Reniera  sp.  [31].
  The  structure 
elucidation of njaoamine G (and H) was achieved by MS and 1D and 2D NMR experiments. The MS 
and signals in the 
13C NMR spectrum were consistent with the molecular formula C39H52N4 that was 
established by HRFABMS (m/z 577.8956, calcd for C39H53N4, 577.8959), suggesting 16 degrees of 
unsaturation.  The thorough analysis of the COSY, TOCSY, HSQC and HMBC experimental data 
contributed to the structure of njaoamine G, a congener of the earlier reported njaoamines [31] and –H, 
both possessing a decan-4-yne chain. The stereochemistry of the alicyclic pentacyclic portion of the 
molecule was deduced from NOESY correlations and confirmed to be comparable to the ‗njaoamines‘ 
and ‗ingenamines‘ families [32–34]. Njaoamine H was shown to be the 9-hydroxy, quinoline, analog.  
Njaoamine G and H were both tested for toxicity to brine shrimp (Artemia salina) and were found to 
be highly active. Njaoamine H showed greater potency with an LD50 value of 0.08 µg/mL; njaoamine 
G had an LD50 value of 0.17 µg/mL [30]. It is worth noting that njaoamines A–F showed cytotoxic 
activity against three human tumor cell lines [30]. Although the present metabolites are structurally 
close to the early reported alkaloids from the sponge Reniera sp. (njaoamines A–F) [31], they give an Mar. Drugs 2010, 8                       
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additional insight into the unique metabolic processes in their construction. The highly potent and 
exceptional brine shrimp toxic activity of njaoamine G and H will encourage us to continue the current 
investigation of their biological activity. 
In  addition  to  the  two  njaoamines,  we  also  isolated  from  the  sponge  extract 
1,2,3,4-tetrahydroquinoline-4-one  (Figure  7),  a  plausible  precursor  of  the  njaoamines.  Though  this 
quinolinone is commercially available, to the best of our knowledge, this is the first report of its origin 
from a natural source. 
Figure 7. The structure of njaoamine G and H (9-OH) and 4-quinolone. 
 
2.5. Nuttingins A–F and Malonganenones D–H 
The extract of the gorgonian Euplexaura nuttingi (Kukenthal, 1919) collected in Uvinage, Pemba 
Island,  Tanzania,  was  found  to  possess  a  moderately  active  apoptosis-inducing  activity.  Positive 
alkaloid  coloring  of  the  extract  of  this  horny  coral  suggested  N-atom-containing  metabolites. 
Gorgonians, well known for production of isoprenoids and polyketide metabolites [35,36], are poor in 
N-atom-containing compounds, and only a few such compounds are known [36]. A recent report on 
tetraprenylated purines, the malonganenones, which possess antiesophageal cancer activity, from the 
Mozambique  gorgonian  Leptogorgia  gilchrist  [37]  encouraged  us  to  report  our  findings  from  the 
Tanzanian gorgonian E. nuttingi. 
Six  new  tetraprenylated  purine  alkaloids,  designated  nuttingins  A–F,  as  well  as  eight 
malonganenones, tetraprenylated alkaloids, of which five (D–H) are new, and three (A–C) known, 
were isolated from this horny coral (Figure 8).  
15N NMR can be a powerful tool for structure determinations of N-atom containing natural products 
[36–40].The suitability of 
15N NMR spectroscopy is attributed to the wide range of chemical shifts and 
its great sensitivity to structural and environmental changes. A major disadvantage of this spectroscopy 
is the extremely low sensitivity of 
15N at the natural abundance level. However, the sensitivity issue 
can be overcome since inverse detection makes it possible to acquire one bond and long-range 
1H-
15N 
correlations, circumventing the low sensitivity, and therefore obtaining 
15N chemical shifts. In previous 
papers we demonstrated the benefit of using 
15N NMR data (NH correlations 
2JNH and 
3JNH HMBC) for 
the  structure  determination  of  various  N-atom-containing  compounds
  including  purine  
derivatives [40,41]. 
The 
1H-
15N  HMBC  of  nuttingin  A  unequivocally  confirmed  the  structure  of  the  proposed 
heterocyclic ring system [42]. 
2JNH correlations observed between H-8 and two vicinal nitrogen atoms 
resonating at 168.7 and 229.7 ppm established these nitrogens to be N-7 (pyrrole sp
3) and N-9 (sp
2). Mar. Drugs 2010, 8                       
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Additional 
2JNH correlations were observed between the two N-methyls to their neighbor N-atoms, i.e., 
between  Me-10  and  a  nitrogen atom resonating at  113.6 (N-3) and between Me-11 and a second 
nitrogen  atom  resonating  at  150.5  ppm  (N-1).  Nuttingins  C–E  are  unstable,  as  was  concluded  by 
monitoring their NMR spectra in CDCl3 or d6-DMSO. Within three to four days in the NMR tube, the 
purine  system  of  the  latter  compounds  changed  into  the  cationic  system  found  in  nuttingin  F. 
Characteristic of this oxidation were the down-field shifts of the two N-methyl signals.  
Together with the nuttingins, three known malonganenones (A–C)
 [37] and five new ones (D–H) 
[42] were also  isolated. The structures  of the latter compounds (Figure 8) was determined by the 
comparison of their NMR data to the known compounds and MS and 2D NMR experiments [37,42]. 
Figure 8. The structures of nuttingins A–F and malonganenones D–H. 
 
Nuttingins A–E and malonganenones D–G have been found to inhibit growth of K562 [43] and UT7 
[44] cells. The tests were done on mixtures of pairs of compounds, as there was no real difference 
between  the  activities  of  compounds  differing  only  in  the side chain. To investigate the potential 
effects of the compounds on cell proliferation, two different human leukemia cell lines, K562 and UT7, 
were used as targets and treated with various concentrations of the tested compound, for 24 and 48 h. 
shown in Nuttingins C-E induced inhibition of cell growth in K562 (A) and UT7 (B), in a dose- and 
time-dependent manner. UT7 cells displayed a greater sensitivity as compared to K562. Namely, at  
0.4 í g/mL nuttingins C to E induced 50% inhibition of cell growth in UT7 cells (B) and 30% in K562 
cells (A), after 48 h of exposure to the compounds. The rest of the new compounds also displayed 
inhibitory  activity  on  proliferation  of  both  cell  lines,  although  they  were  approximately  3-fold  
less potent.  
2.6. Isohalitulin and Haliclorensins B and C 
Halitulin and haliclorensin are two unique alkaloids isolated in our group from the marine sponge 
Haliclona  tulearensis  collected  in  Sodwana  Bay,  Durban,  South  Africa  [45,46].  The  significant 
cytotoxicity of haliclorensin against P-388 mouse leukemia cells and that of halitulin against several Mar. Drugs 2010, 8                       
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tumor cell lines has stimulated studies toward the total syntheses of both molecules [47–49]. Steglich 
and Banwell’s syntheses of haliclorensin [49] allowed the revision of its structure (Figure 9), and the 
initially  assigned  structure  for  haliclorensin  was  subsequently  renamed  isohaliclorensin  [49,50]. 
Furthermore, it was suggested that both the initially proposed structure (the azacyclodecane precursor 
of  halitulin)  and  the  revised  structure,  originate  from  a  common  1,11-diazabicyclo[8,4]tetradecane 
[47]. Two recent reports on the total synthesis of halitulin confirmed its structure and allowed the 
determination of its absolute (17S) configuration [47,50]. 
Figure 9. The structure of Haliclona tulearensis N-atom containing metabolites. 
 
Together with halitulin and haliclorensin, an additional related compound was isolated from the 
same sponge [45,46]. Because this compound was isolated in minute amounts and was highly sensitive 
to light and air, the structure elucidation was not accomplished. As part of our ongoing search for novel 
bioactive substances  from  marine invertebrates, we resumed our work on  Haliclona sponges.  The 
constituents  of  two  Madagascan  Haliclona  tulearensis  sponge  specimens  were  examined  with  the 
purpose of finding additional interesting metabolites and hopefully to, once again, isolate the above 
mentioned sensitive compound and complete its elucidation.  
Indeed, the two new samples of Haliclona tulearensis, collected at Salary Bay, circa 100 km north 
of Tulear, Madagascar, contained three new alkaloids designated isohalitulin (the compound searched 
for) and haliclorensins B and C (Figure 9).  
The structures of all three were elucidated by MS and 1D and 2D NMR spectra. Isohalitulin is a 
structural  isomer  of  halitulin  where  a  change  of  the  hydroxyl  position  on  the  quinoline  system 
occurs [51]. 
Haliclorensins B and C represent novel N-atom containing compounds [51]. To the best of our 
knowledge,  the  only  naturally  reported  tetrahydropyrimidinium  ring,  as  in  haliclorensin  B,  is  the 
pyrrole-derived alkaloid N-methylmanzacidin C isolated from the sponge Axinella breVistyla [52]. 
Indeed, the tetrahydropyrimidinium ring by itself is known synthetically [53,54]. Haliclorensin C joins 
two other marine, naturally occurring azacycloalkanes, i.e., keramaphidine C (6Z-azacycloundecene), 
the first reported marine azamacrocycle [55] and haliclorensin 7-methyl-1,5-diazacyclotetradecane. On 
the  grounds  of  common  biogenetic  precursors,  it  is  tentatively  suggested  that  isohalitulin  and 
haliclorensins B and C have the same absolute configuration of the single stereogenic center (S) as 
determined for halitulin and haliclorensin. Mar. Drugs 2010, 8                       
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Obtaining different secondary metabolites from the two Salary Bay collections of H. tulearensis and 
from a sample collected on the other side of the Mozambique Canal raises the question of the real 
source of the compounds, namely, the sponge or guest microorganisms. Isohalitulin and haliclorensins 
B and C were tested for toxicity to brine shrimp (Artemia salina) and were found to be moderately 
active. Isohalitulin shows a greater potency, with a LD50 value of 0.9 mM, while haliclorensins B and 
C have LD50 values of 2.2 and 2.1 mM, respectively. 
3. Introduction to the Fascaplysinopsis sp. Metabolites 
In  continuation  of  our  investigation  of  Madagascar  marine  sponges,  we  have  investigated  the 
Fascaplysinopsis sp. sponge collected in Salary Bay circa 100 km north of Tulear. The identification 
of this spicule-less sponge genus by Professor Vacelet, Marseille, was not straightforward. It seems to 
be  closest  to  Fascaplysinopsis  (Demospongiae,  order  Dictyoceratid,  family  Thorectidae)  a  genus 
described thus far only from Australia and Indonesia. 
From this organism we have isolated and elucidated the structure of four groups of unprecedented 
cytotoxic nitrogenous macrolides i.e., salarins (A–J) [56,57,61,62] tulearins (A–C) [56,59] taumycins 
(A  and  B)  [58]  and  a  fourth  group,  combining  taumycin  and  salarin,  designated  tausalarins  (C) 
(Figure 10) [60].  
Figure 10. Salarins, tulearins, taumycins and tausalarins, four new groups of metabolites 
from the Madagascr sponge Fascaplysinopsis sp. 
 
 
All four groups are novel classes of marine natural compounds embodying unprecedented structures 
with rare or even naturally unknown functional moieties. The structure similarity of the four groups to Mar. Drugs 2010, 8                       
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microorganism  and  fungal  metabolites  (e.g.,  to  the  cyanobacteria  Lyngbia  bouillonii  metabolites, 
madangolide  and  laingolide  A)  [63,64],  suggested  that  these  compounds  originate  from  guest 
microorganisms  rather than from  the host  sponge itself. This  notion is supported by the chemical 
content variations from one collection to the other. During the last four years we collected the sponge 
several  dozen  times  from  different  spots  in  Salary  Bay  and  found  remarkable  differences  in  
their metabolites. 
The extracts of the Madagascar Fascaplysinopsis sp. were found to be active in the brine shrimp test 
as well as cytotoxic to leukemia cells. All compounds were evaluated for their cytotoxicity against 
K562  [43]  and  UT-7  [44]  human  leukemia  cells  lines,  using  the  colorimetric  methylthiazole 
tetrazolium  bromide  (MTT)  assay  [62].  Salarin  C  was  found  to  be  the  most  potent  compound, 
exhibiting  significant  inhibitory  activity  against  the  leukemia  cell  lines,  UT-7  and  K562,  and  the 
murine pro B cell line Ba/F3 at concentrations of 0.0005–0.5 g/mL [62]. 
3.1. Salarins A–J 
Salarin‘s  A  formula  was  determined  from  the  mass  spectrometric  as  well  as  the  carbon-NMR 
analysis suggesting a molecular formula of C35H46N2O12 (HRESMS m/z 709.2991 for [M + Na]
+, with 
14 degrees of unsaturation. Comprehensive analysis of the 1D and 2D NMR data including the spectra 
of the N-methyl derivative, vide infra, and comparison with model compounds led to the suggested 
structure (Figure 11) [56]. 
Figure 11. The ten Fascaaplysinopsis sp. salarins (A–J). 
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Worth mentioning is the outstanding low field double doublet at ʴ 8.21 (J = 15.7 and 11.3 Hz), in 
moiety (d) (Figure 13) characteristic for a 2Z, 4E geometry. This exceptionally low field signal agrees 
only with the 2Z, 4E isomer and requires a carbonyl at position C-6 [65]. 
The  naturally  unique  N-acetyl  carbamate  group of salarin  A was  suggested following CH-  and 
NH-HMBC experiments (ʴN 143 ppm) [56] and was in good agreement with the acidity of the imide 
proton, among the two carbonyls, which could be methylated with CH3I, in the presence of K2CO3 in 
acetone, to afford the N-CH3 derivative (ʴH 3.23s, ʴC 30.3q). 
After lengthy crystallization trials a crystalline structure of salarin A suitable for X-ray diffraction 
analysis was obtained and the relative configuration of the six chiral centers achieved [60] (Figure 12). 
Figure 12. Wire frame model and ORTEP representation of salarin A, obtained by X-ray 
diffraction analysis. 
 
Salarin B analyzed for C36H52N2O13 from the HRESMS (m/z 741.3028 [M + K]
+), with 13 degrees 
of  unsaturation.  The  NMR  data  pointed  to  high  similarity  to  salarin  A,  disagreeing only in  three 
functional moieties. That is, -B lacks the 16,17-epoxide, differs in the C-14 to C-17 site, and also lacks 
the triacylamine group (f), vide suppra. Instead of the latter functionality, -B possesses, as part of the 
macrolide a lactam group carrying next to the nitrogen atom (on C-6), a methoxyl and a methyl ketone 
(Figure  11).  The  latter  unique  moiety  resembles  a  similar  rare  functionality  in  the  Aspergillus 
metabolite  synerazol  [66].  The  structure  of  the  C5–C9  segment  was  suggested  on  the  basis  of 
2D NMR data.  
Both salarin A and B possess novel macrolide structures. Not only in the triacylamine and the 
-substituted lactam functionalites, but also in the construction of the macrolide from two carbon Mar. Drugs 2010, 8                       
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chains (a 6-amidohexa-2,4-dienoic acid and a functionalized C15-carboxylic acid). It is also feasible 
that the nitrogenous macrolide is obtained by a Beckmann rearrangement of an -ketooxime of a 
single chain, namely, introducing a nitrogen atom into the chain which can afford an amide or oxazole 
[67] (Scheme 5). A similar combination of two chains can be found in the two above mentioned 
nitrogenous macrolides madangolide and laingolide A [63] isolated from the cyanobacteria Lyngbia 
bouillonii [64]. 
From  yet  another  collection  of  the  Fascaplysinopsis  sp.  sponge,  we  isolated  several  additional 
compounds including one bright orange in color which was closely related to salarins A and B and 
designated salarin C (Figure 13). 
Figure 13. COSY ( ), and key 
13 CH- and 
15NH-HMBC correlations of salarin C. 
 
The  mass  spectroscopic  analysis  of  salarin  C  provided  a  pseudo  molecular  formula  of 
C35H46N2O10Na,  HRESIMS,  m/z  677.3035  for  [M  +  Na]
+  (calcd.  677.3044),  with  14  degrees  of 
unsaturation. The 
1H, 
13C, COSY, HSQC, TOCSY, and HMBC spectra [57] (Figure 13), established 
the structure of salarin C. The major change was the replacement of the triacylamine subunit of salarin 
A by an oxazole ring in salarin C, evidenced by the 
15N resonance-value, measured from the 
3J(CH-N) 
HMBC correlation, of ʴ 245.0 ppm [68] (in addition to the ʴ 143.0 ppm shift of the acetyl carbamate 
nitrogen atom) (Figure 13). 
Oxazoles  are  widely  present  in  biologically  active  natural  compounds.  It  was  believed that the 
oxazole rings were biosynthesized from amino acids, namely from serine or threonine. The amino acid 
origin of oxazoles in cyclic peptides such as bistratamide is most likely, and it has even been proven in 
epothilone  D,  for  example  [69].  However,  oxazole  precursors  in  the  marine  natural  compounds 
calyculins,  phorbazoles  and  mycalolide  were  recently  proposed  by  Uemura  to  be  obtained  via  a 
different  route involving Beckman rearrangement of ʱ-formyl ketoximes [67]. Similarly, it can be 
suggested that the oxazole ring of salarin C is obtained from an ʱ-acetyl ketoxime as depicted in 
Scheme 5. Of prime interest was finding in the literature that oxazoles ring open under oxidative 
conditions to afford with 
1O2 the triacylamine moiety [70] and under mild basic bromine-oxidation, an 
amidomethoxy ketone [71]. Salarins A and B are precisely the expected products from salarin C under 
analogous biosynthetic oxidations. Detailed suggested mechanisms leading to salarins A and B from C 
are depicted in Scheme 6. Mar. Drugs 2010, 8                       
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Scheme 5. Suggested biogenetic of the oxazole ring of salarin C [63]. 
 
Unexpectedly, stirring salarin C in chloroform slowly afforded salarin A (ca. 50% in 2–3 days; over 
a longer period, isomerization of the ʱ,β,γ,ʴ-dienoate takes place). However, it was found that an 
efficient transformation of salarin C to -A, almost quantitatively, takes place when a thin layer of 
salarin C over glass, was left over night in the air under light.  
The  anti-proliferative  activity  of  salarin  C  was  dose-dependent;  salarin  C  at  concentrations  of 
0.0005–0.5 mg/mL was added to the cells for 24 hours, and cell viability was determined by MTT 
assay. Salarin C was by far more potent than salarins A and B and tulearin A [62]. In addition to the 
above  salarins,  we  have  isolated  seven  others  (D–J)  in  minute  amounts.  The  following  structure 
elucidations/discussions are grouped according to their similarity to salarins A–C, the first group being 
salarins E, G and H (Figure 11).  
Scheme 6. Suggested biogenetic transformations of salarin C to salarins A, B and D. 
 
Comparison of the 
1H and 
13C NMR data of salarin E [61] with those of salarin A [56], indicated 
high similarity; the major distinction being the absence of the 6-N-acetyl resonance, replaced by a NH 
singlet at 7.96 ppm. The chirality of the six stereogenic carbon-atoms is assumed to stay unchanged. Mar. Drugs 2010, 8                       
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The HRESIMS spectrum of salarin G exhibited a pseudomolecular ion [M + Na]
+ at m/z 745.2727 
suggesting,  together  with  the 
13C  spectrum,  the  molecular  formula  C35H47ClN2O12,  implying  13 
degrees of unsaturation. The presence of one chlorine atom in the molecule was further confirmed by 
two dominant sodiated pseudomolecular ions [M + Na]
+ at m/z 745.3 and 747.3 with intensities of 
1/0.33  in  the  ESIMS  spectrum.  Inspection  of  the 
1H  and 
13C  NMR  features  of  salarin  G  closely 
resembled those of -A except for changes in the side chain. Namely, the 16(17)-epoxide is replaced by 
a 16-oxymethine-17-chloromethine functionality. Assuming salarin A to be the precursor of salarin G, 
it  can  be  suggested  that  the  original  epoxide-oxygen  atom  retains  its  configuration  while  the 
configuration of the chlorinated allylic C-17 atom is unknown. To exclude the possibility that salarins 
G and F, vide infra, are artifacts, products of HCl opening of the epoxide of salarin A or C, we treated 
salarin A with traces of DCl in CDCl3 and monitored the proton NMR. It was found that salarin A is 
relatively stable under these mild acidic conditions for 48 h and then, as with higher concentrations of 
acid, affords complex mixtures and not a single chlorohydrin. 
Salarin H, the third congener of salarin A, possesses the formula C35H48N2O13, i.e., addition of a 
molecule of water to salarin A. Comprehensive analysis of the NMR data, 2D experiments [61] and 
comparison with former congeners, established for salarin H the 16,19-dihydroxy-17-ene structure. 
Obtaining the latter moiety can be explained by acid catalyzed opening of the 16(17)-epoxide of -A, 
followed  by  allylic  rearrangement  of  the  initially  obtained  18-ene-17-carbocation  intermediate 
(Figure 14).  
Figure 14. Transformations of salarin A and/or C. 
 
A congener of salarin B is salarin D exhibiting a pseudomolecular ion [M + Na]
+ at m/z 725.3205 
suggesting,  together  with  the 
13C  NMR  data,  the  molecular  formula  C36H50N2O12,  thus  implying 
13 degrees of unsaturation [61]. The 1D and 2D NMR spectra of -D revealed a close relationship with Mar. Drugs 2010, 8                       
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salarin B, that is, -D possessing the same methoxymethylketone lactam moiety (the C6–C8 segment); 
the major change being a 16(17)-epoxide in -D, in addition to the 12(13)-epoxide [56,57]. 
Two additional isolated congeners of salarin C are salarin F and I (Figure 11). Salarin F possesses 
the oxazole ring of -C and the 16-hydroxy-17-chloro-moiety of salarin G. Salarin I, a relatively polar 
compound, on the other hand, misses the two epoxides and possesses, in addition to the oxazole ring, a 
12,13,16,19-tetraol-17-ene functionality [61].  
The tenth salarin, salarin J, exhibited a pseudomolecular ion [M + Na]
+ at m/z 667.2827, suggesting, 
together with the 
13C NMR spectrum, the C33H44N2O11 molecular formula, indicating 13 degrees of 
unsaturation. Hence, salarin J was implied to be a structural isomer of -D, differing according to the 
NMR data only in the C(14–17) site. That is, the 16(17)-epoxide, is replaced by a 2,3-dioxygenated 
tetrahydrofurane ring [an ethereal bridge between C-14 (ʴC 82.5 d) and C-17 (ʴC 82.1 d)] [61]. The 
epoxy-THF (C-12 to C-17) moiety of salarin J was found to be obtained by treating salarin A with 
MgBr2 as shown in Figure 14. 
Finally, the earlier reported structure of the salarin  B [56] was  amended. The original structure 
implied one 12(13)-epoxide and a 16,17-diol. Indeed, the HRESIMS at m/z 703.2 was by 18 mu short, 
than anticipated [56,61] (Figure 11). 
Worth mentioning are transannular NOE correlations between H-4 and H-13 observed for salarin-I, 
-C  and  -F  and  not  for  other  salarins.  It  becomes  clear  that  even  small  structural  changes  in  the 
macrolide change its preferred conformation. 
3.2. Tulearins A–C 
The second group of isolated compounds composes the three tulearins, A–C [56,59] (Figure 15). 
The HREIMS of tulearin A [56] exhibited a molecular ion [M + Na]
+ at m/z 558.3757 proving, 
together with the carbon NMR spectrum, a formula of C31H53NO6Na, with six degrees of unsaturation. 
The structure of tulearin A was established by 1D and 2D NMR data [56]. Tulearin's A core is a 
2,4,15,19-tetramethylated hexaeicosanoic polyketide acid, possessing a 18 membered lactone (from 
C-1 to C-17), carrying on the macrolide chain, besides two hydroxyls (on C-3 and 9), also a carbamate 
(on C-8). The carbamate function is rare in nature, known for example in palmerolide A, recently 
isolated from a tunicate [72] or in the microorganism derived macrolide, geldanamycin [73]. 
Within  the  framework  of  a  structure-activity  relationship  (SAR)  study  of  the  tulearins,  we 
investigated the effects of a variety of reagents on the molecule in order to change the six functional 
moieties. Among others, we treated tulearin A with different bases in order to change the carbamate 
and/or the macrolide-lactone group, and also attempted to obtain tulearin C, vide infra, (Figure 15). 
Treatment of tulearin A with a mixture of aq ammonia/MeOH (1:1), afforded a less polar compound as 
colorless crystals in 83% yield. The structure of the latter compound was established to be the cyclic 
8,9-carbonate derivative. Fortunately, the crystals of this carbonate were suitable for X-ray diffraction 
analysis, thus confirming tulearin‘s A structure and establishing the relative configuration of all seven 
chiral centers. The molecular structure of tulearin‘s A carbonate is depicted in Figure 15. Mar. Drugs 2010, 8                       
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Figure 15. The structures of tulearins A–C, the cyclic 8,9-carbonate and MTPA-ester derivative. 
 
The  absolute  stereochemistry  of  tulearin  A  was  determined  by  the  modified  Mosher‘s 
method [74].The technique utilizes anisotropic shifts induced in the 
1H NMR spectra of a-methoxy-a-
(trifluoromethyl)  phenylacetic  (MTPA)  esters  of  secondary  alcohols  to  define  the  absolute 
configuration. Both (+)-(R)-(1R) and (-)-(S)-(1S) MTPA esters of tulearin A were prepared (Figure 15) 
and  the    values  from  their  500  MHz 
1H  NMR  spectra  were  calculated    
[ (S-MTPA ester) − (R-MTPA ester)]. Using this method, the absolute configuration of C-9 was 
determined to be S, hence, on the basis of the X-ray structure, the absolute configuration of the other 
chiral  centers  of  tulearins  A,  B,  and  C  (assuming  the  three  to  have  a  common  biosynthesis)  is 
2R,3R,5S,8S,9S,15R, and 17S [59]. It is important to stress that, as required in the modified Mosher‘s 
method, all the assigned protons with positive and negative values are actually found on the right and 
left sides of the MTPA plane (MTPA-C-9 to C-4), respectively. Also, the absolute values of  are 
inversely proportional to the distance from the MTPA moiety. 
Two  additional  tulearins  obtained  from  the  Fascaplysinopsis  sp.  in  very  minor  amounts  were 
designated  as  tulearin  B  and  C.  Tulearin  B  was  determined  to  be  the  3,8-dicarbamate  analog  of 
tulearin A and tulearin C the 3,8,9-trihydroxy precursor of the tulearins [59]. 
3.3. Taumycin A and B 
Together with  the salarins and tulearins, we have isolated two closely related lipodepsipeptides 
named taumycins A and B (Figure 16) [58]. The HRCIMS of taumycin A revealed a pseudo molecular 
ion [M + H]
+ at m/z 558.3559, corresponding to a molecular formula of C31H47N3O6 (Δ = 1.56 mmu) 
requiring 10 degrees of unsaturation. The structure of taumycin A was established from the 
1H, 
13C, 
COSY,  HSQC,  TOCSY,  and  HMBC  spectra  (Figure  16)  [58],  creating  a  12-membered 
lipodepsipeptide. The attachment of the chain to the oxazole ring i.e., to C-13 or C-14 was evidenced 
from 
1JCH values of CH(14) and CH(19), namely, 197 and 230 Hz, respectively. The latter values, 
measured from a ‖Gated‖ experiment, were compared to published values for 4- and 5-substituted 
oxazoles [75], hence, it could be concluded that the chain is attached to C-13 (the 5 position of the 
oxazole ring). The relative chirality of the four chiral centers of the depsipeptide was determined by 
Marfey‘s  method  [58].  The  impossibility  to  distinguish  between  the  position  of  the  L  and  D  Ile 
positions in the ring prevented assignment of the absolute configuration.  Mar. Drugs 2010, 8                       
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Figure 16. The structure of taumycin A and B and 2D correlations for taumycin A. 
 
A 14-aminotetradecanoic moiety is known in nature, for example, in erythromycin; however, as the 
latter originates from seven molecules of propionate, there are, alternately, seven methyl groups in the 
molecule. In the taumycins, on the other hand, only three out of the four methyl groups are alternating. 
Twelve-membered cyclic depsipeptides as in the taumycins are rare. Hapalosin, the first reported 
[76], as well as the recently reported acremolides A–D [77] and stereocalpin A [78], are all derived 
from microorganisms; the first from a cyanobacteria, the second from a marine-derived fungus, and the 
third  from  an  Antarctic  lichen.  It  is  therefore  very  likely  that  the  taumycins  also  derive  from 
microorganism(s) living within the sponge. Taumycin A and B are toxic to brine shrimp larvae with 
IC50 values of 10 μg/mL. Taumycin A, at 1 μM, inhibited growth of the erythropoietin taumycin B as 
well  as  several  derivatives  of  taumycin  A  which  did  not  possess  an  antiproliferative  effect  on  
these cells. 
3.4. Tausalarin C  
From three collections of the sponge, carried out in Salary Bay, in a depth of 25–35 m, we have 
isolated  another  metabolite  designated  tausalarin  C  (0.012%  dry  wet)  (Figure  16)  [60].  Spectral 
similarities of the NMR data of the latter compound to that of salarin A [56] and taumycin A [58], led 
us first to think that we were dealing with a 1:1 mixture of two compounds; however, unsuccessful 
HPLC separation efforts and mainly NMR correlations from one half of the molecule to the other, and 
at last, unmistakably, the HRESIMS spectrum, resulted in the slightly modified salarin A to taumycin 
A joint-structure. The mass spectroscopic analysis and 
13C resonance values of tausalarin C, provided a 
pseudo molecular formula of C66H95N5O19Na in the positive HRESIMS mode, m/z 1284.6519, mmu 
1.9 ppm, for [M + Na]
+ and in the negative mode suitable [M − H]
− and [M + Cl]
−, 1260.6586 and
 
1296.6310, mmu 1.5 ppm, peaks, respectively, implying 22 degrees of unsaturation. The 
1H, 
13C, 
COSY, HSQC, TOCSY, and HMBC spectra [60] established the conjugated structure of the compound 
as depicted in Figure 17. It became clear that the 16,17-epoxide of a salarin A molecule opened up by a Mar. Drugs 2010, 8                       
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nucleophilic amine attack. A bond from the latter nitrogen atom to C-17 of the opened epoxide moiety, 
of salarin A, connected the two parts of the molecule, one to the other, as established by the HMBC 
and NOE correlations completing the structure of tausalarin C (Figure 17) [60]. Interestingly, it was 
found that the 16,17-epoxide of salarin C can be opened, similarly to what is suggested for tausalarin 
C, selectively, with an amine and a suitable Lewis acid, to afford the 16-hydroxy-17-amino derivative 
(Scheme 7). 
Figure 17. The structure of tausalarin C and connecting key 2D NMR correlations. 
 
On  the  basis  of  the  suggested  biogenesis  of  tausalarin  C  (Scheme  7),  the  relative 
stereochemistry of the corresponding five stereogenic centers (C-12 to C-16) have to be the same 
as in salarin A and the chiral centers in the second half, the same as in taumycin A. The distance 
between the two halves of the molecule and the absence of meaningful NOE‘s between the two halves 
prevented  the  determination  of  the  relative  mutual  stereochemistry  between  the  two  parts  of 
the molecule. 
The effect of tausalarin C on cell proliferation was determined in two different human leukemic cell 
lines,  K562
 [43]  and  UT7  [44]  using  the  colorimetric  methylthiazole  tetrazolium  bromide  (MTT) 
assay
 [62] tausalarin C at 1 µM, inhibited 35%, 65% and 74% of K562 growth after 24 h, 48 h and 
72 h, respectively—lower activity than measured for the separate two halves. Notably, tausalarin C did 
not significantly inhibit proliferation of the UT7 cells. 
In addition to the four new groups of compounds we also isolated other known sponge metabolites, 
namely, a unique cyclitol glycolipid, crasseride [79] and several sterols including 5,8-peroxysterols, 
9,11-secosterol carboxaldehyde [80]. 
 
 
 Mar. Drugs 2010, 8                       
 
 
2831 
Scheme 7. Suggested biogenesis on tausalarin C. 
 
4. Conclusions  
The  nitrogenous  marine  natural  products  presented  above,  describe  only  a  few  of  the  N-atom 
containing structures obtained from marine organisms. The wide scope of compounds, many of which 
possessing biological activities, exhibit the potential of the marine environment for novel structures 
and drug leads. Nature still seems to be without competition in the synthesis of novel outstanding 
compounds. The biogenesis of many of the new compounds is intriguing. While a biogenesis could be 
described for a few compounds like eilatin and violatinctamine, vide supra, the bio-synthesis of many 
others of the isolated compounds is debatable. In addition to the structure determination methodology, 
the review also reveals the problem of identifying the real source of the isolated compounds. Success 
in  isolating  microorganisms  responsible  for  the  synthesis  of  interesting  compounds  is  of  utmost 
importance for the supply of the latter compounds for biological tasks.  
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